COMPANY PROFILE // THE 014 REPORT
TRex Bio, Inc.
TRXB (Nasdaq)
Assembled from 2 government sources in 2.1 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
No flag from the records checked. 26 of 26 lists and sources checked came back clear (panel below).
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
TRex Bio, Inc. is an SEC-registered operating company in biological products, (no diagnostic substances), incorporated in DE, based in South San Francisco, CA; listed as TRXB (Nasdaq).[source] It has filed 40 documents with the SEC in the last 12 months; the latest is Form 10-Q, filed 2026-11-13.[source] Every list and source checked for this page came back clear (26 of 26), dated in the checks panel.[source]
- red0
- amber0
- info0
- CLEAR26
- POSSIBLE MATCH0
- MATCH0
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0002139097 | source |
| EIN | 00-0000000 | source |
| Business address (SEC) | C/O TREX BIO, INC., SOUTH SAN FRANCISCO, CA | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; <br>Emerging growth company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; <br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2836 (biological products, (no diagnostic substances)): 183 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- AMGEN INC · 123 SEC filings in 12 months · 1 flag · $507.4M federal (possible match)
- Vir Biotechnology, Inc. · 117 SEC filings in 12 months · 1 flag · $65.9M federal (possible match)
- Vericel Corp · 109 SEC filings in 12 months · 1 flag · $37.3M federal (possible match)
- Coherus Oncology, Inc. · 53 SEC filings in 12 months · 3 flags · $11.8M federal (possible match)
- BIO-TECHNE Corp · 77 SEC filings in 12 months · 1 flag · $6.6M federal (possible match)
- Twist Bioscience Corp · 337 SEC filings in 12 months · 2 flags · $5.9M federal (possible match)
- Adaptive Biotechnologies Corp · 185 SEC filings in 12 months · 1 flag · $1.9M federal (possible match)
- AGENUS INC · 82 SEC filings in 12 months · 3 flags · $613K federal (possible match)
- REPLIGEN CORP · 89 SEC filings in 12 months · 1 flag · $457K federal (possible match)
- Revolution Medicines, Inc. · 171 SEC filings in 12 months · 2 flags · $15K federal (possible match)
- RECURSION PHARMACEUTICALS, INC. · 174 SEC filings in 12 months · 1 flag
- GILEAD SCIENCES, INC. · 173 SEC filings in 12 months
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-13 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-13 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-10-16 filing SCHEDULE 13D · SEC EDGAR
- 2026-10-16 filing SCHEDULE 13D · SEC EDGAR
- 2026-10-13 filing 8-K items 5.03,9.01 · SEC EDGAR
- 2026-10-09 filing S-8 · SEC EDGAR
- 2026-10-09 filing 424B4 · SEC EDGAR
- 2026-10-08 filing EFFECT · SEC EDGAR
- 2026-10-08 filing CERT · SEC EDGAR
- 2026-10-06 filing 8-A12B · SEC EDGAR
- 2026-10-05 filing S-1/A · SEC EDGAR
- 2026-09-18 filing Registration (S-1) · SEC EDGAR
- 2026-08-21 filing DRS/A · SEC EDGAR
- 2026-07-31 filing DRS/A · SEC EDGAR
- 2026-06-26 filing DRS · SEC EDGAR
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-13 (within 7 days) 10-Q filed
- 2026-11-13 (within 7 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-13 (older) 8-K filed: Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-10-09 (older) S-8 filed
- 2026-10-09 (older) 424B4 filed
- 2026-10-08 (older) EFFECT filed
- 2026-10-08 (older) CERT filed
- 2026-10-06 (older) 8-A12B filed
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:TRXB The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
1 possible match held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 2139097 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | TRXB / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| CUSIP | 89531N100 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0002139097 | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-20 09:55 UTC | Report an error |
| SIC industry | 2836 Biological Products, (No Diagnostic Substances) | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-20 09:55 UTC | Report an error |
| State of incorporation | DE | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-20 09:55 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-20 09:55 UTC | Report an error |
| Business address | C/O TREX BIO, INC., 269 EAST GRAND AVENUE SUITE 300, SOUTH SAN FRANCISCO, CA | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-20 09:55 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-13 | SEC EDGAR company profile | as filed | 2026-11-20 09:55 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-13 · accession 0001193125-26-460786
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Net income (loss) | -$13,239,000 | 3 months ended 2026-09-30 | 10-Q | 2026-11-13 | 0001193125-26-460786 | 2026-11-20 09:55 UTC | Report an error |
| Cash and cash equivalents | $16,810,000 | at 2026-09-30 | 10-Q | 2026-11-13 | 0001193125-26-460786 | 2026-11-20 09:55 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-13 Filing 10-Q filed
- 2026-11-13 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-13 Filing 8-K filed: Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-10-09 Filing S-8 filed
- 2026-10-09 Filing 424B4 filed
- 2026-10-08 Filing EFFECT filed
- 2026-10-08 Filing CERT filed
- 2026-10-06 Filing 8-A12B filed
- 2026-10-05 Filing S-1/A filed
- 2026-09-18 Filing S-1 filed
- 2026-08-21 Filing DRS/A filed
- 2026-07-31 Filing DRS/A filed
- 2026-06-26 Filing DRS filed
8-K item text, as filed (excerpts)
- 2026-11-13 8-K Item 2.02, Results of Operations and Financial Condition
On November 13, 2026, TRex Bio, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the quarter ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing by the Company under the Securities Act of 1933, as… the 8-K · retrieved 2026-11-20 09:55 UTC - 2026-10-13 8-K Item 5.03, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
On October 13, 2026, in connection with the consummation of the initial public offering (the “IPO”) of shares of common stock, par value $0.0001 per share, of the Company (“Common Stock”), the Company filed a fourth amended and restated certificate of incorporation (the “Amended and Restated Certificate”) with the Secretary of State of the State of Delaware, which became effective upon filing. The Company’s board of directors and stockholders previously approved the Amended and Restated Certificate to be filed in connection with, and to be effective upon, the consummation of the IPO. The Amended and Restated Certificate amends and restates the Company’s certificate of incorporation in its… the 8-K · retrieved 2026-11-20 09:55 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
1 state and city record carry this company's exact name, from 1 source. Possible matches only.
ClinicalTrials.gov (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchTRex Bio, Inc. · exact legal name · sx:ctgov:hc62dfd7cc8c4d736 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/2139097.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0002139097. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.